ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
77.95
+0.23 (0.30%)
Jul 21, 2026, 12:56 PM EDT - Market open
ANI Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, ANI Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $110. The average 1-year stock price forecast is 41.12% higher than the current stock price, while the lowest is $91 (+16.74%) and the highest is $124 (+59.08%).
Price Target: $110 (+41.12%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ANI Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Initiates $91 | Hold | Initiates | $91 | +16.74% | Jul 16, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $124 | Buy | Maintains | $124 | +59.08% | Jul 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $121 | Buy | Maintains | $121 | +55.23% | Jul 13, 2026 |
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +28.29% | May 20, 2026 |
| Truist Financial | Truist Financial | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 11, 2026 |
Financial Forecast
Revenue This Year
1.12B
from 883.37M
Increased by 26.99%
Revenue Next Year
1.24B
from 1.12B
Increased by 10.71%
EPS This Year
9.42
from 7.89
Increased by 19.41%
EPS Next Year
10.76
from 9.42
Increased by 14.25%
EPS and Forward PE are based on non-GAAP adjusted numbers.